T cell subpopulations and activated T cells of peripheral blood in controls and in patients with active and inactive polymyositis
| p Values | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients with aPM (n = 13) | Patients with iPM (n = 37) | Controls (n = 32) | aPM v control | iPM v control | aPM viPM | |||||||
| Values are mean (SD). | ||||||||||||
| The samples were measured by flow cytometry and lymphocytes were identified on the basis of their scatter properties. | ||||||||||||
| aPM, active polymyositis; iPM, inactive polymyositis. | ||||||||||||
| CD3+ cells (%) | 66.2 (9.4) | 70.4 (8.1) | 70.3 (7.2) | NS | NS | NS | ||||||
| CD4+ cells (%) | 42.3 (12.4) | 46.9 (9.8) | 45.2 (7.6) | NS | NS | NS | ||||||
| CD8+ cells (%) | 21.6 (10.2) | 20.6 (6.4) | 19.6 (5.9) | NS | NS | NS | ||||||
| CD19+ cells (%) | 13.8 (7.4) | 10.9 (7.4) | 11.7 (4.1) | NS | NS | NS | ||||||
| CD3+ and HLADR+ cells (%) | 13.6 (14.3) | 9.4 (7.8) | 3.0 (2.3) | p<0.01 | p<0.01 | NS | ||||||
| CD3+ and CD69+ cells (%) | 1.5 (1.0) | 1.2 (0.9) | 1.0 (0.8) | NS | NS | NS | ||||||